Guenther Koehne

4.1k total citations
98 papers, 2.0k citations indexed

About

Guenther Koehne is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, Guenther Koehne has authored 98 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 33 papers in Oncology and 27 papers in Immunology. Recurrent topics in Guenther Koehne's work include Hematopoietic Stem Cell Transplantation (37 papers), Multiple Myeloma Research and Treatments (34 papers) and Cytomegalovirus and herpesvirus research (22 papers). Guenther Koehne is often cited by papers focused on Hematopoietic Stem Cell Transplantation (37 papers), Multiple Myeloma Research and Treatments (34 papers) and Cytomegalovirus and herpesvirus research (22 papers). Guenther Koehne collaborates with scholars based in United States, Spain and Germany. Guenther Koehne's co-authors include Richard J. O’Reilly, Susan E. Prockop, Ekaterina Doubrovina, Sergio Giralt, Miguel‐Angel Perales, Aisha Hasan, Sean M. Devlin, Humilidad F. Gallardo, Juliet N. Barker and Craig S. Sauter and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Nature Biotechnology.

In The Last Decade

Guenther Koehne

95 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guenther Koehne United States	25	898	777	695	520	446	98	2.0k
Kathryn Leung United States	16	1.0k 1.1×	511 0.7×	727 1.0×	839 1.6×	290 0.7×	50	2.1k
Alfred P. Gillio United States	21	1.2k 1.4×	1.1k 1.4×	712 1.0×	474 0.9×	527 1.2×	49	2.7k
Polina Stepensky Israel	28	500 0.6×	536 0.7×	1.2k 1.8×	294 0.6×	693 1.6×	134	2.5k
Atsushi Wake Japan	26	656 0.7×	1.2k 1.5×	694 1.0×	281 0.5×	446 1.0×	125	2.2k
Stéphane Vigouroux France	22	583 0.6×	691 0.9×	641 0.9×	146 0.3×	341 0.8×	50	1.7k
João F. Lacerda Portugal	18	457 0.5×	533 0.7×	622 0.9×	282 0.5×	215 0.5×	59	1.4k
BR Blazar United States	20	828 0.9×	971 1.2×	1.1k 1.6×	339 0.7×	193 0.4×	38	2.2k
Ahmet Elmaağaclı Germany	31	576 0.6×	1.8k 2.3×	1.1k 1.6×	468 0.9×	432 1.0×	82	2.8k
Joanne Luider Canada	22	357 0.4×	516 0.7×	431 0.6×	157 0.3×	329 0.7×	55	1.4k
Tessa Kerre Belgium	26	769 0.9×	427 0.5×	940 1.4×	121 0.2×	670 1.5×	112	2.1k

Countries citing papers authored by Guenther Koehne

Since Specialization

Citations

This map shows the geographic impact of Guenther Koehne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guenther Koehne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guenther Koehne more than expected).

Fields of papers citing papers by Guenther Koehne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guenther Koehne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guenther Koehne. The network helps show where Guenther Koehne may publish in the future.

Co-authorship network of co-authors of Guenther Koehne

This figure shows the co-authorship network connecting the top 25 collaborators of Guenther Koehne. A scholar is included among the top collaborators of Guenther Koehne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guenther Koehne. Guenther Koehne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winthrop, Kevin, Scott Beegle, Guenther Koehne, et al.. (2022). Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial. Open Forum Infectious Diseases. 9(7). ofac232–ofac232. 10 indexed citations

Lahoud, Oscar, Sean M. Devlin, Molly Maloy, et al.. (2021). Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter’s transformation. Blood Advances. 5(14). 2879–2889. 18 indexed citations

Bachier‐Rodriguez, Lizamarie, Gunjan L. Shah, Andrea Knežević, et al.. (2018). Engraftment Kinetics after High-Dose Melphalan Autologous Stem Cell Transplant in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 24(3). S144–S144. 2 indexed citations

Shah, Gunjan L., Andrew Lin, Ryan Schofield, et al.. (2017). Feasibility, Tolerability, and Patient-Reported Outcomes with Pharmacokinetic (PK)-Directed Dosing of Evomela® (propylene glycol free melphalan) for Multiple Myeloma and AL Amyloidosis Patients Undergoing Autologous Hematopoietic Stem Cell Transplant (AHCT). Blood. 130. 2023–2023. 2 indexed citations

Shah, Gunjan L., Heather Landau, Ryan Schofield, et al.. (2017). Pharmacokinetics and Toxicities after Evomela® (propylene glycol free melphalan) with Autologous Hematopoietic Stem Cell Transplant (AHCT) for Multiple Myeloma and AL Amyloidosis. Blood. 130. 3296–3296. 2 indexed citations

Spitzer, Barbara, Ann A. Jakubowski, Esperanza B. Papadopoulos, et al.. (2017). A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of Blood and Marrow Transplantation. 23(12). 2088–2095. 8 indexed citations

Jakubowski, Ann A., Molly Maloy, Patrick Hilden, et al.. (2017). T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 23(10). 1685–1694. 11 indexed citations

Shah, Gunjan L., Kenneth Seier, Sean M. Devlin, et al.. (2017). Re-immunization following Autologous Hematopoietic Stem Cell Transplantation (Auto HCT) is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance. Clinical Lymphoma Myeloma & Leukemia. 17(1). e82–e83. 1 indexed citations

Koehne, Guenther, Sean M. Devlin, David J. Chung, et al.. (2017). WT1 heteroclitic epitope immunization following autologous stem cell transplantation in patients with high-risk multiple myeloma (MM).. Journal of Clinical Oncology. 35(15_suppl). 8016–8016. 2 indexed citations

10.

Smith, Eric L., Sean M. Devlin, Satyajit Kosuri, et al.. (2015). CD34-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Relapsed, High-Risk Multiple Myeloma. Biology of Blood and Marrow Transplantation. 22(2). 258–267. 18 indexed citations

11.

Lendvai, Nikoletta, Sean M. Devlin, Minal Patel, et al.. (2015). Biomarkers of Cardiotoxicity Among Multiple Myeloma Patients Subsequently Treated with Proteasome Inhibitor Therapy. Blood. 126(23). 4257–4257. 7 indexed citations

12.

Koehne, Guenther, Satyajit Kosuri, Ekaterina Doubrovina, et al.. (2015). Wilms´Tumor 1 Protein Is Highly Expressed on Malignant Plasma Cells and Provides a Novel Target for Immunotherapeutic Approaches. Blood. 126(23). 98–98. 1 indexed citations

13.

Lendvai, Nikoletta, Patrick Hilden, Sean M. Devlin, et al.. (2014). A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma. Blood. 124(6). 899–906. 65 indexed citations

14.

Jungbluth, Achim A., et al.. (2012). WT1-Specific T-Cell Responses Following T Cell-Depleted Allogeneic Hematopoietic Stem Cell Transplantation and Donor Lymphocyte Infusions in Patients with High-Risk Multiple Myeloma. Biology of Blood and Marrow Transplantation. 18(2). S294–S295. 1 indexed citations

15.

Koehne, Guenther & Sergio Giralt. (2012). Allogeneic hematopoietic stem cell transplantation for multiple myeloma. Current Opinion in Oncology. 24(6). 720–726. 14 indexed citations

16.

Jakubowski, Ann A., Trudy N. Small, Nancy A. Kernan, et al.. (2011). T Cell–Depleted Unrelated Donor Stem Cell Transplantation Provides Favorable Disease-Free Survival for Adults with Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 17(9). 1335–1342. 56 indexed citations

17.

Barker, Juliet N., Ekaterina Doubrovina, Craig S. Sauter, et al.. (2010). Successful treatment of EBV-associated posttransplantation lymphoma after cord blood transplantation using third-party EBV-specific cytotoxic T lymphocytes. Blood. 116(23). 5045–5049. 163 indexed citations

18.

Zanzonico, Pat, Guenther Koehne, Humilidad F. Gallardo, et al.. (2006). [131I]FIAU labeling of genetically transduced, tumor-reactive lymphocytes: cell-level dosimetry and dose-dependent toxicity. European Journal of Nuclear Medicine and Molecular Imaging. 33(9). 988–997. 30 indexed citations

19.

Karadimitris, Anastasios, Rosario Notaro, Guenther Koehne, Irene Roberts, & Lucio Luzzatto. (2000). PNH cells are as sensitive to T-cell-mediated lysis as their normal counterparts: implications for the pathogenesis of paroxysmal nocturnal haemoglobinuria. British Journal of Haematology. 111(4). 1158–1163. 30 indexed citations

20.

Koehne, Guenther, et al.. (1971). Sporotrichosis in a Dog. Journal of the American Veterinary Medical Association. 159(7). 892–894. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact